Influence of a low sodium diet on the renal response to amino acid infusions in humans. In experimental animals, a high protein diet has been shown to accelerate end-stage renal disease by inducing glomerular hyperperfusion. In this study, we found that intravenous administration of amino acid, used as one component of parenteral nutrition, to normal volunteers resulted in a significant increase in renal blood flow (from 517 29 to 754 60 mI/mm) and glomerular filtration rate (from 106 6 to 165 12 mI/mm) without altering systemic blood pressure, renal excretion of electrolytes, plasma renin activity, or plasma aldosterone concentration, and excretory rates of prostaglandins E2 were increased (from 665 61 to 1,034 153 pg/mm). These amino acid-induced renal hemodynamic effects were abolished when the volunteers received a low sodium diet (20 mEq/day) for three days before the amino acid infusions. However, the hemodynamic effects were restored when the subjects receiving low sodium diets were pretreated with captopril. Under these conditions, amino acid infusions increased renal blood flow (from 388 11 to 597 27 mI/mm) and glomerular filtration rate (from 80 4 to 118 9 mI/mm). Reduction of prostaglandin synthesis with indomethacin in volunteers receiving a normal sodium intake was also capable of significantly decreasing the amino acid effects on renal hemodynamics. The results indicate that the renal hemodynamic effects of amino acid infusion are strongly influenced by angiotensin II and prostaglandin formation.
It is known that a high protein diet produces a significant increase in both renal blood flow (RBF) and glomerular filtration rate (GFR) [1] [2] [3] [4] [5] [6] [7] . The mechanisms underlying these renal hemodynamic effects are unknown [1, 2] , but they may be related to increased concentration of amino acids in blood because significant increments in GFR have been reported to occur during the intravenous administration of amino acid combinations used in parenteral nutrition [7, 8] . However, the administration of individual amino acids into the renal artery has failed to either elicit a comparable vasodilatory effect or increase GFR [121. These findings and the observation that the renal vasodilatation induced by a high protein diet is at least in part hormonally mediated [13] [14] [15] [16] have fostered the notion that the overall effects of protein components on renal function involve a complex homeostatic response. This concept has raised our can be modified by sodium dietary restrictions, which elicit opposite changes in renal hemodynamics. This question has considerable clinical significance because a low sodium intake is regularly administered in most pathologic situations in which high protein diets are held theoretically responsible for accelerating glomerular damage, mainly renal insufficiency [3] and hypertension [1] . Furthermore, determinations of increments in GFR induced by protein load [17] or amino acid infusions [8] have been suggested to be a reliable index of renal reserve, although it is not known whether such an effect could be altered by changes in dietary sodium.
This study was therefore undertaken to characterize fully the effects of amino acid combinations on renal hemodynamics and on renal excretory function and to determine whether these effects could be influenced by sodium dietary restriction. A low sodium diet was found to be efficacious in preventing the renal hemodynamic effects of amino acid infusions, and this preventive action was reversed by blocking the formation of angiotensin II with a converting enzyme inhibitor. Because prostaglandins seem to be important for modulating glomerular dynamics [181, we also attempted to determine whether the renal responses to amino acid infusions are modified during treatment with indomethacin and a normal sodium intake.
Methods

Human volunteers
The study was conducted in 13 healthy volunteers (7 men and 6 women; age range, 24 to 31 years). At the time of admission, the volunteers had a complete clinical workup; renal function was determined to be normal from results of standard laboratory tests on blood and urine, including creatinine clearance.
After giving written informed consent, approved by the institutional review board, they were hospitalized the night before the study, and the last meal of unrestricted sodium intake was taken at 8 p.m. The experimental protocols were conducted at 8 a.m. the following day. At the completion of the study, the subjects were closely monitored for symptoms compatible with urinary infection. In no instance was there a need for further medication. 
Studies of the effects of amino acid infusions
The effects of amino acid infusions were studied in nine (6 men and 3 women) of the 11 volunteers; the two other volunteers were used for control studies in which the effects of standard solutions that did not contain amino acid were tested. All subjects lay comfortably in the supine position. The clearances of inulin (C1) and para-aminohippurate (CPAH) were determined during diuresis, which was elicited by the oral ingestion of 20 ml of water/kg of body wt during 20 minutes. The accurate collection of urine was ensured by use of an indwelling bladder catheter. After an intravenous bolus of inulin and para-aminohippurate (both substances in 5% dextrose solution were infused through a butterfly needle inserted into the antecubital vein), infusion was maintained by a constant-infusion pump (Harvard Apparatus Co., Inc., South Natick, Massachusetts, USA). After a 45-minute equilibration period, the bladder was emptied, and two, 30-minute control clearances were measured. All the control values reported herein for renal clearances and urine determinations are the average of two periods in each subject. Blood samples were drawn at the midpoint of each clearance through a butterfly needle inserted into the contralateral antecubital vein; plasma levels of inulin, para-aminohippurate, sodium, potassium, plasma renin activity (PRA), and aldosterone were measured. After the control clearances, a 10% amino acid solution used for parenteral nutrition (Table 1 ) was added to the perfusate at a rate of 0.75 mllkg per hour. The total osmolality of the amino acid infusate was 280 mOsm/liter. The infusion was continued for six hours, and clearances were measured during the last 30 minutes of each two hour period. Urine samples were appropriately processed to measure sodium, potassium, calcium, and phosphate.
Control studies were performed to ensure that the observed effects were induced by amino acids rather than by the diluent solutions. Two of the 11 volunteers were submitted to a protocol identical to that described above for amino acid infusions except that after the control clearances, which were also measured by using similar concentrations of inulin and para-aminohippurate in 5% dextrose solutions, a 0.9% NaCl physiologic solution that did not contain amino acid was added to the perfusate. The total amount of the physiologic solution infused was identical to that of the amino acid solution, and the total osmolality was adjusted to 280 mOsm/liter by adding sterilized distilled water.
Studies during a low sodium diet
Seven of the nine patients who received amino acid infusions were restudied after dietary sodium restriction. Sodium depletion was achieved by administering a single oral dose of furosemide (80 mg) and a diet containing 20 mEq of sodium and 40 mEq of potassium for three days before the experiment, which was performed on the morning of the fourth day. The protocol was identical to that used for amino acid infusions in the untreated control volunteers.
Studies during a low sodium diet after pretreatment with captopril Five of the seven patients in whom the amino acid infusions were performed during a low sodium diet underwent a five-day recovery period, during which the total amount of sodium intake was unrestricted. After these five days of recovery, furosemide was administered and a low sodium diet was reinstituted for three days. The efficacy of the low sodium diet to reduce fluid volumes was ensured by an average reduction of body weight of 4.3 0.2 kg and a reduction in the 24-hour urine sodium value to an average of 21.2 2.1 mEq/24 hours during the three days. On the fourth day, the patients received an oral dose (25 mg) of captopril (E. R. Squibb & Sons, Inc., Princeton, New Jersey, USA) one-half hour before the control period clearance studies were performed.
Indomethacin studies
Seven of the nine patients who received amino acid infusions during a normal sodium diet underwent a three day recovery period, after which the effects of amino acid infusion during a normal sodium diet were again studied after the administration of indomethacin. Indomethacin, 25 mg twice a day for two days before the study, was given orally, and the last dose was given on the morning of the study. The adequacy of inhibition of prostaglandin synthesis was confirmed by measuring the urinary excretion of prostaglandin E2 (PGE2), as outlined below.
Chemical, hormonal, and blood pressure measurements
The concentrations of para-aminohippurate and inulin in the blood and urine were estimated by photocolorimetric methods [19] , and the concentrations of sodium and potassium were estimated by flame photometry (Instrumentation Laboratory, mc, model 343, Lexington, Massachusetts, USA). Urine calcium was measured by atomic absorption (Perkin-Elmer, Corp., model 460, Norwalk, Connecticut, USA), and urine phosphate was measured by the molybdenum blue colorimetric reaction.
During the procedure, blood pressure was measured every 15 minutes with an automatic recorder (Dynamap Model 845, Critikon, Inc., Tampa, Florida, USA). 
Results
Amino acid infusions during a normal sodium diet The individual responses of GRF and RBF to amino acid infusions in subjects receiving a normal sodium diet varied significantly ( Fig. 1) , particularly during the first two hours of the infusion. Thereafter, GFR and RBF followed a significant upward trend. The average changes in renal hemodynamics, electrolyte excretion, urinary PGE2, PRA, and plasma aldosterone are presented in (Table 2) . RBF was unchanged after two hours of amino acid infusions, but it increased significantly (P < 0.01) at four and six hours, by 19% and 46%, respectively.
A similar change was observed for GFR, in which the control value was maintained during the first two hours of amino acid infusion but increased at four and six hours, by 31% and 56%, respectively (P <0.01). These marked changes in renal hemodynamics were not accompanied by any significant change in systemic blood pressure; the control values (systolic SE! The observed increase in the GFR represented a maximal elevation of the filtered load of sodium of 57%; however, this change was not accompanied by any significant alteration in urine volume or in the absolute urinary excretion of sodium. The fractional excretions of sodium, potassium, calcium, and phosphate also remained constant (Table 2) .
Furthermore, the hemodynamic changes were not accompanied by any alteration in PRA or plasma aldosterone. PGE2 progressively increased by 55%; the differences from the control value was statistically significant only at six hours during the infusion.
These results contrast with those obtained in two volunteers who received a normal sodium diet and were submitted to a similar experimental protocol except that an equivalent volume of saline that did not contain amino acids was given with the intravenous infusions of 5% dextrose solutions used for determinations of renal clearances. In these subjects, the recorded averages the range of GFR during the control period Eq/min), PGE2 (from 652 160 to 661 163 pg/mm), PRA (from 1.8 0.8 to 1.9 0.6 ng/ml per hour) and plasma aldosterone (from 2.4 0.8 to 2.6 0.5 ngldl) were not significant.
Amino acid infusions during a low sodium diet When the effects of amino acid infusion after sodium depletion were analyzed (Table 3) , the control values for most of the measurements were significantly different from those obtained during the control period in subjects receiving normal sodium diets (Table 2 ). In fact, the administration of furosemide and three days of sodium dietary restriction induced reductions in 994 RBF of 13% (P <0.05), in urinary volume of 19% (P < 0.05), and in urinary sodium excretion of 78% (P < 0.01). These changes were accompanied by approximately 2.2-fold increases in both PRA (P < 0.01) and plasma aldosterone (P < 0.01), and urinary POE2 increased 21% (P < 0.05). The control values for blood pressure were also significantly (P < 0. Under the condition of sodium restriction, the effects of amino acid infusion on renal hemodynamics were significantly suppressed. The average GFR and RBF values increased after six hours of infusion by only 10% and 8%, respectively; these changes were not statistically significant. Amino acid infusions during a low sodium diet after pretreatment with captopril
When the effects of amino acid infusions during a low sodium diet in subjects pretreated with captopril were studied (Table 4) , the administration of captopril 30 minutes before the experiment resulted in control values for GFR and RBF that were 23% and 14%, respectively, lower than the control values obtained in the same subjects during a sodium restricted diet without receiving captopril (Table 3) (P < 0.01). Captopril also decreased (P < 0.01) the control value for urinary sodium excretion by 75% but did not alter the value for PRA or aldosterone or the urinary excretion rates of POE2.
The infusion of amino acids after the administration of captopril induced hemodynamic changes comparable to those obtained in the same subjects when they were untreated and receiving a normal sodium diet (Table 4) . A significant (P < 0.01) increased in the RBF of 21% occurred at four hours and of 53% at six hours; the GFR increased by 27% at four hours and by 47% at six hours, although this increment achieved statistical significance (P < 0.01) only at six hours. In addition, the administration of amino acids to the sodium deprived subjects who received captopril induced significant (P <0.01) elevations of both sodium excretion and the levels of PRA, effects that did not occur when amino acids were given to subjects while they received a normal or low sodium diet. However, the levels of plasma aldosterone remained unaltered. Urine volume and the total and fractional sodium excretion were significantly (P <0.01) increased by 70%, 84%, and 58%, respectively, and the value for PRA also increased, by approximately threefold (P < 0.001). The infusions of amino acids failed to alter the increased urinary excretion rate of POE2, which exhibited a higher individual variability.
Control levels of systemic blood pressure (91 3/56 3 mm Hg) were significantly lower (P <0.05) than when the subjects received a low sodium diet without captopril pretreatment.
Blood pressure did not change during amino acid infusion (93 3/56 5 mm Hg at two hours, 90 5/56 1 mm Hg at four hours, and 89 2/55 4 mm Hg at six hours). Amino acid infusions during a normal sodium diet after administration of indomethacin
The patients who received a normal sodium diet and were pretreated with indomethacin (50 mg/day) for two days prior to the experiment also received an additional dose of 50 mg 30 minutes before the determinations for the control period.
The control values for renal hemodynamics and excretion (Table 5) were not significantly different from those in the same subjects while they received a similar intake of sodium but no indomethacin (Table 2) . However, PRA, plasma aldosterone, and PGE2 were significantly decreased by 42% (P < 0.05), 58%
(P < 0.05), and 83% (P < 0.01), respectively. After pretreatment with indomethacin, systemic blood pressure (112 5/76 3 mm Hg) was not different from that of subjects who did not receive indomethacin and did not change at two (115 4/80 6 mm Hg), four (110 6/78 5 mm Hg), or six hours (114 5/74 6 mm Hg) of amino acid infusion. The administration of indomethacin resulted in a complete suppression of the increments in GFR that the amino acid infusion induced in the untreated control group (Table 2) , and it significantly (P < 0.05) blunted the increase of RBF by 62%. As in the control group, the amino acid infusion failed to induce any significant change in the other renal secretory and hormonal values, including PGE2, which remained suppressed throughout the experiment.
When the percentage changes in RBF and GFR induced by amino acid infusions in the control group of subjects on normal sodium diet were compared with those of the three experimental groups (Fig. 2) , the profile of increments elicited by amino acid infusion in the subjects receiving a normal sodium diet was very similar to that in subjects receiving a low sodium diet and captopril. This profile contrasts with the lack of significant changes exhibited by the subjects receiving a low sodium diet but no captopril and those receiving a normal sodium diet pretreated with indomethacin.
Discussion
Renal effects of amino acid infusions in subjects receiving a normal sodium intake
This study shows that, in agreement with the reports of other investigators [7, 8] , administration of an amino acid solution that is commonly infused as one component of parenteral Hemodynamic changes. Although the mechanism that mediates the renal effects of amino acids remains poorly defined, dietary protein load [4, 17] or amino acid infusions [8] have been used to estimate renal reserve of glomerular filtration. This value, which is defined as the ability of the kidney to increase GFR over resting conditions, was estimated in 28% at 60 and 120 minutes when using a dietary protein load [17] , whereas a 14.5% increase in GFR was measured at 24 to 48 hours during an infusion of amino acid combination [8] . More recently, 37.5% and 45% increments in GFR and RBF, respectively, were reported to occur in normals two hours after protein load [24] . Differences in the values of GFR reported in these studies and in ours could be accounted for by differences in experimental design, in the relative efficacy of protein load with respect to amino acid infusions, in the dose and composition of amino acid preparation, and in the circulating levels of amino acids. Our results indicate that determinations of renal reserve can be largely influenced by changes in dietary sodium, fluctuations of which are difficult to control in free dietary regimens.
Changes in renal excretory function. An important result of our study was that a 50% increment in RBF and GFR was not followed by any significant change in renal excretory function. These effects on RBF resemble those produced by substances such as secretin or PGE2 synthetic analogues, which are also capable of inducing renal vasodilatation without changes in sodium excretion [25, 26] . The natriuretic effect of vasodilators is largely dependent on their ability to increase renal interstitial pressure, as is the case with acetylcholine [27] and bradykinin [28] . On the basis of these findings, one is tempted to speculate that amino acid-induced renal vasodilatation may not be accompanied by changes in interstitial pressure. However, no study has yet been performed to confirm this possibility.
Another possibility by which the increments in GFR may not be translated into a significant natriuresis is by assuming an increase in proximal tubular sodium reabsorption similar to the increase in the tubular sodium load. Such an assumption was suggested recently in studies showing that amino acid combinations could greatly stimulate sodium reabsorption in proximal tubules to the point of decreasing the total amount of fluid flow that reaches the distal nephron [29] . Such a decrease in distal tubular flow was suggested to induce, through a tubuloglomerular feedback mechanism, an afferent arteriolar vasodilatation with an associated increase in GFR. Thus, this hypothesis provides the conceptual elements that explain not only the lack of renal sodium excretion during amino acid infusion but also the parallel increment in RBF and GFR. Changes in PRA and PGE2. Our study also revealed that the amino acid-induced renal vasodilatation is not accompanied by any significant change in peripheral levels of PRA. To a large extent, this finding could be explained because, during the experimental period, no acute and significant changes in systemic blood pressure, cardiovascular volume balance, or urinary volume and osmolality occurred that could be incriminated as responsible for altering renin release through changes in renal nerve sympathetic-activity [30, 31] , intrarenal baroreceptors [32] , or macula densa receptors [33] . However, during amino acid infusions, an increase in the excretion rate of PGE2 achieved statistical significance in urine samples collected at six hours of infusion. Because prostaglandins exert a strong stimulatory influence on renin release [34, 35] , one would have expected a similar change in PRA. This hypothesis assumes that the overall variations in renal prostaglandin synthesis are accurately reflected in changes of PGE2 excretory rates [36, 37] . Such an assumption, however, should be constrained by experimental evidence showing that PGI2 may be the only prostaglandin capable of modulating renin release [38, 39] and that urinary excretion of POE2 may not be accompanied by changes in the synthesis of P012 at the level of the juxtaglomerular apparatus [40] . Similarly, limited information about the actual amount of prostaglandins that could effectively diffuse from the renal parenchyma to the urine may explain why the urinary excretion rate of these substances did not increase in parallel to the hemodynamic changes, except at six hours after the amino acid infusions.
Effects of sodium dietary restriction on renal actions produced by amino acid infusions.
In the present study, sodium dietary restriction was followed by the expected decrease in the urinary excretion of sodium and a concomitant increase in plasma levels of renin and aldosterone and in the urinary excretion rate of prostaglandins [41] . Under these conditions, the hemodynamic increments induced by amino acid infusions were completely abolished, and, as in controls, the infusions had no effect on the existing elevated levels of PRA and plasma aldosterone or on the urinary excretion rate of prostaglandins. The decreased urinary excretion rate of sodium also remained unaltered.
The major clinical implication of this finding is that it questions the possibility of a deleterious effect of a high protein diet in patients with essential hypertension and normal renal function in whom sodium intake is significantly restricted or in whom a low balance of sodium has been instituted by appropriate administration of diuretics [42] [43] [44] . Additional studies of the manner in which changes in dietary sodium could alter the renal effects of protein intake in hypertension should be conducted to elucidate this important issue.
Effects of inhibition of converting enzymes on the amino acid-induced renal changes during sodium restriction
The renin-angiotensin system seems to occupy a predominant place among the renal vasoconstrictor factors activated by volume depletion subsequent to a low sodium diet. In fact, several studies indicate that, under these conditions, the increased production of angiotensin II is responsible for a decrease in renal hemodynamics [31, 45, 46] and also for sodium retention [31, 41, 45] , which is facilitated not only by increased levels of aldosterone [31, 33, 45] but also by direct effects that angiotensin exerts on both renal vasculature and renal tubules [31, 46] . These findings lend strong support to the assumption that suppression of the formation of angiotensin II with captopril in sodium depleted subjects was the major factor in both restoring the hemodynamic effects of amino acid infusions and fostering the associated natriuresis. An important participation of prostaglandins in restoring the hemodynamic effects of amino acids after treatment with captopril is difficult to conceive because the urinary excretion rates are no different than those measured in untreated subjects receiving a sodium restricted diet in whom amino acid infusions fail to induce renal changes.
It should be mentioned that inhibition of converting enzyme or kininase II decreases kinin metabolism [47] . However, because of the undefined role of kinins in renal function [481, it is difficult to determine how an excessive formation of kinins could restore the hemodynamic effects of amino acids. In addition, we have found that, in dogs, a 90% inhibition of angiotensin I conversion is accompanied by a significant potentiation to bradykinin vascular responses in mesenteric and iliac vascular beds but not in the renal vasculature [49] .
Effects of indomethacin on amino acid-induced changes in renal hemodynamics
Evidence indicates that the regulation of glomerular dynamics is principally exerted by the renin-angiotensin and the prostaglandin systems [50] . For this reason, we decided to study the effects of blockade of prostaglandin synthesis on the renal hemodynamic response to amino acid infusion. In subjects receiving a normal sodium diet, the administered dose of indomethacin produced a reduction in urinary prostaglandins of 16% of the excretory rate measured in the untreated control group under identical dietary conditions. This decrease in prostaglandin synthesis was accompanied by a decrease in the levels of PRA and plasma aldosterone similar to that reported previously by us [41] and by other investigators [35, [50] [51] [52] . The effect of indomethacin on resting values of renal hemodynamics is also in agreement with our previous observation [41] that blockade of prostaglandin synthesis is not expected to produce a significant change in either RBF or GFR when indomethacin is given to subjects receiving a normal sodium intake. Under this condition, the effects of amino acid infusions on GFR were completely prevented, whereas the increments in RBF were blunted by 50% when compared with untreated control subjects receiving a normal sodium intake. These observations seem to favor the notion that basal synthesis of prostaglandins is needed to facilitate the effect of amino acids on renal hemodynamics and that such prostaglandin permissive actions are critical for the elevation of GFR. Such an interpretation will have to be ascertained with further studies because the concomitant decrease in PRA that followed the administration of indomethacin could have hampered the efficacy of prostaglandin synthesis blockade to prevent the renal hemodynamic changes completely.
In summary, our study shows that amino acid-induced hemodynamic effects on the kidney are extensively modulated by angiotensin II and prostaglandins. These renal hemodynamic actions of amino acids may not occur during conditions in which renin activity has been increased (such as a low sodium diet) but are restored when angiotensin II formation is abolished by converting enzyme inhibitors. Similarly, a decrease in prostaglandin synthesis could significantly decrease the amino acid-induced hemodynamic effects by removing their permissive effects.
